William Baumgartl, MD
Interventional Pain Medicine · Antioch, CANPI 1528004496
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,611 of the $12,900 with a category attached, or 82.3%. It is spread thinly across 38 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,970 and has fallen 73.4% since, to $789 in 2025.
Across 389 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$2K
- Nevro Corp.$2K
- Boston Scientific$2K
- Biohaven Pharmaceuticals, Inc.$1K
- Scilex Pharmaceuticals Inc.$1K
- Collegium Pharmaceutical, Inc.$561
- plus $4K from 32 others
What the payments were for
- Consulting fees$1,2009%
- Travel & lodging$1,0768%
- Food & beverage$10,61182%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 38 | $2,395 |
| Nevro Corp. | 28 | $2,101 |
| Boston Scientific | 53 | $1,547 |
| Biohaven Pharmaceuticals, Inc. | 2 | $1,217 |
| Scilex Pharmaceuticals Inc. | 74 | $1,030 |
| Collegium Pharmaceutical, Inc. | 38 | $561 |
| Medtronic(2 entities) | 15 | $360 |
| Abbott | 11 | $358 |
| Zyla Life Sciences, Inc. | 34 | $304 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $290 |
| Amgen | 9 | $245 |
| Vertos Medical, Inc. | 3 | $229 |
| Xtant Medical Inc | 1 | $205 |
| Nutech Spine, Inc. | 1 | $187 |
| Globus Medical | 4 | $184 |
| Stimwave Technologies Incorporated | 1 | $180 |
| Arbor Pharmaceuticals, Inc. | 14 | $175 |
| Relievant Medsystems, Inc. | 4 | $158 |
| Smith+Nephew | 1 | $144 |
| GRT US Holding, Inc. | 1 | $131 |
| USWM, LLC | 6 | $116 |
| Biodelivery Sciences International, Inc. | 7 | $113 |
| Eisai Inc. | 5 | $93 |
| Forte Bio-pharma LLC | 2 | $90 |
| SPR Therapeutics, Inc | 2 | $85 |
| Tersera Therapeutics LLC | 4 | $60 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Novartis | 2 | $37 |
| Redhill Biopharma Inc. | 2 | $37 |
| Assertio Therapeutics, Inc. | 3 | $36 |
| Sentynl Therapeutics, Inc. | 2 | $33 |
| Radius Health, Inc. | 2 | $32 |
| Painteq LLC | 1 | $29 |
| Protega Pharmaceutials Inc | 1 | $26 |
| AbbVie | 1 | $24 |
| Pfizer | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| MDD US Operations, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$1,549
- NURTEC ODT$1,200
- Senza Spinal Cord Stimulation System$984
- Omnia$375
- Senza$242
- SiFix$187
- mild Device Kit$160
- STRAVIX PL$144
- Proclaim IPG$142
- Qutenza$131
- EVENITY$122
- OSTEOCOOL RF ABLATION$103
- WaveWriter Alpha Prime 16$100
How this compares
$12,900 in reported general payments places this provider in the 80th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 22 | $20,864 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 317 | $10,233 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 109 | $4,734 |
| Zonisamide | 64 | $2,109 |
| Tizanidine Hcl | 109 | $1,072 |
| Gabapentin | 75 | $1,044 |
| Lidocaine | 11 | $747 |
| Baclofen | 22 | $708 |
| Pregabalin | 47 | $685 |
| Oxycodone Hcl | 42 | $614 |
| Naproxen | 14 | $605 |
| Cyclobenzaprine Hcl | 55 | $417 |
| Tramadol Hcl | 52 | $368 |
| Celecoxib | 14 | $365 |
| Cephalexin | 39 | $355 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Antioch
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
- Phillip LimBuena Park$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.